InspireMD Inc. is a leading medical device company focusing on innovative embolic prevention systems and neurovascular devices. Its primary mission is to improve the outcome of vascular procedures with its proprietary MicroNet™ technology, which is designed to significantly improve the efficacy and safety of stenting procedures. InspireMD is particularly influential in the interventional cardiology and neurovascular sectors, targeting severe cardiovascular conditions such as carotid artery disease and coronary artery disease. The company is headquartered in Tel Aviv, Israel, and serves a global market, distributing its products in numerous countries. As a key player in the medical device industry, InspireMD strives to reduce the risks associated with stenting, such as embolization and restenosis, thus aiming to enhance patient care and safety in critical medical interventions. Its commitment to advancing medical technology makes InspireMD a pivotal entity in the ongoing effort to innovate and improve healthcare delivery worldwide.